SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

What happens when you give Claude Code a blank webpage, and full control?

The Best Website Ever

BWE is trending amidst bearish sentiment, with traders actively shorting and anticipating further drops. The community expresses concerns about potential market manipulation and broader economic anxieties such as inflation, tariffs, and a possible recession impacting crypto.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending as the community discusses its potential for a breakout, pointing to its historical significance as "silver to Bitcoin's gold." Conversations also revolve around the implementation of MWEB for enhanced privacy and scalability, with some anticipating a significant price surge. Despite some skepticism, many community members express optimism for Litecoin's future, citing its established utility and upcoming developments.

Kusama is a public blockchain network that is running the exact same codebase as Polkadot. It is aimed to be a canary build for the Polkadot network which is an experimental and development environment for new features that will eventually be deployed to Polkadot. Because of the experimental nature of Kusama, the developmental speed is much faster and it has seen significant traction since launched in 2019.  Kusama is an early, highly experimental version of Polkadot presenting real economic conditions. The community will own the network – there will be no central kill switch. Kusama will exist as long as its community maintains it and we envision it will cater to new, early functionality and projects preparing to develop and deploy on Polkadot.

Kusama 

Kusama (KSM) is trending amid discussions about its potential for significant gains, drawing comparisons to past performance and its role as Polkadot's canary network. The community is closely watching KSM, with some highlighting oversold RSI conditions and anticipating a price surge, while others discuss staking rewards and potential migration updates.

SSgA Active Trust - Consumer Discretionary Select Sector SPDR

Consumer Discretionary Select Sector SPDR Fund

The Consumer Discretionary Select Sector SPDR Fund ($XLY) is trending as traders assess the strength of the consumer amid mixed signals. Recent data points, including retail sales and consumer confidence, are being weighed alongside potential impacts from tariffs and concerns about a slowing economy. Community discussion revolves around key support and resistance levels, as well as potential sector rotation and signals from related stocks like $TSLA and $AMZN.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is trending as the community discusses recent price action and its potential for an upcoming bull run, with some speculating about its quantum-resistant properties and the potential impact of new partnerships. The Folks Finance airdrop is also generating buzz, as users share their experiences with claiming tokens and discuss the DeFi landscape. Some traders believe a breakout is coming, while others remain skeptical about ALGO's long-term prospects.

BtcUSD is a completely decentralized stablecoin issued and managed by BTCFi, a platform where users can deposit Bitcoin of various formats to use as collaterals. BtcUSD offers Bitcoin holders the opportunity to generate additional yields with their Bitcoin positions through DeFi usage.

Bitcoin USD (BTCFi)

Bitcoin is trending as the community debates its short-term bearish signals versus long-term bullish potential, with some eyeing key support levels and others anticipating a parabolic move towards new highs. Discussions range from Elliott Wave analysis suggesting further downside to predictions of a major rise based on historical patterns and increasing institutional ownership. Bullish sentiment revolves around Bitcoin's fixed supply and anticipation of increased demand, with some projecting targets well above previous all-time highs.

Niagen Bioscience, Inc. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. It is pioneering research on nicotinamide adenine dinucleotide (NAD+). The company’s patent portfolio includes Nicotinamide Riboside (NR) and other NAD+ precursors, which are commercialized as the flagship ingredient Niagen. It operates through the following segments: Consumer Products, Ingredients, and Analytical Reference Standards and Services. The Consumer Products segment provides finished dietary supplement products that contain the firm’s proprietary ingredients directly to consumers as well as to distributors. The Ingredients segment supplies ingredients as raw materials to the manufacturers of consumer products. The Analytical Reference Standards and Services segment includes supply of phytochemical reference standards and other research and development services. The company was founded by Mark S. Germain and Frank L. Jaksch, Jr. in 1999 and is headquartered in Los Angeles, CA.

Niagen Bioscience Inc.

Niagen Bioscience is trending due to discussions around recent earnings beats and a newly announced share repurchase program, signaling confidence from leadership. Community members are actively sharing research related to NAD+ and its potential benefits in areas like cognitive decline, muscle health, and even counteracting muscle loss from GLP-1 drugs.  Ongoing clinical trials and potential pharmaceutical partnerships are also key talking points driving interest in NAGE.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR Protocol is currently trending amidst discussions about its user growth and potential within the AI sector. Community members are weighing in on entry points and breakout setups, while some highlight NEAR's rise in active users compared to other blockchains. There's also buzz around staking opportunities and upcoming events related to NEAR's ecosystem.

ZIGChain (ZIG) is a purpose-built Layer 1 blockchain for wealth generation. Powered by an innovative wealth management module, ZIGChain enables anyone to co-invest alongside professional fund managers in real-world assets (RWAs), while supporting institutional adoption and regulatory compliance. At the heart of this democratized investment ecosystem is the ZIG token, which powers governance, transaction validation, and incentivizes network growth.

ZIGChain

ZIGChain is trending amid discussions of its recent mainnet launch and potential partnerships, particularly with $SALARY. Community members are analyzing technical indicators, with some pointing to bullish breakouts and upside continuation, while others caution about potential distribution phases and downside risks. The coin's association with AI-powered DeFi and RWA tokenization is also fueling interest.

BJ's Wholesale Club Holdings, Inc. engages in the operation of membership warehouse clubs. Its product categories include grocery, household and pet, television and electronics, furniture, computer and tablets, patio and outdoor living, lawn and garden, baby and kids, toys, home, health and beauty, appliances, and jewelry. The company was founded in 1984 and is headquartered in Marlborough, MA.

BJ`s Wholesale Club Holdings Inc

BJ's Wholesale Club is trending amid discussion of potential options trading opportunities and upcoming earnings, with community members sharing bullish sentiments and discussing possible price movements. Some analysts have adjusted their ratings and price targets, while others discuss the company's financials, digital transformation, and competition within the wholesale retail sector. There is also some discussion of insider selling and comparison to competitors like Costco.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

FibroGen, Inc. (FGEN) on Monday said that a Chinese regulator has approved the sale of its unit FibroGen International (Hong Kong) to AstraZeneca (AZN).FibroGen had announced the sale of its China unit to AstraZeneca for about $160 million in February. The closing of the transaction is now expected in the third quarter of 2025, the company <a target="_blank" rel="noopener noreferrer nofollow" href="https://investor.fibrogen.com/news-releases/news-release-details/fibrogen-announces-approval-sale-fibrogen-china-astrazeneca">said</a>. &nbsp;The closing of the transaction remains subject to other contractual closing conditions and deliverables, the biopharmaceutical company added. The firm had previously expected the transaction to close by mid-2025. On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/FGEN">FGEN</a> trended in the ‘extremely bullish’ territory over the past 24 hours, while message volume remained at ‘extremely high’ levels.The company said earlier this year that it would repay its term loan facility to investment funds managed by Morgan Stanley Tactical Value following the closing of its transaction in a bid to simplify its capital structure. The transaction is further expected to extend the company’s cash runway into 2027, it added.Upon closing, AstraZeneca will obtain all rights to Roxadustat in China. Roxadustat is currently approved in China, Europe, Japan, and numerous other countries for the treatment of anemia in chronic kidney disease (CKD) patients, irrespective of whether they are on dialysis.The company is currently considering a development plan for Roxadustat in anemia associated with lower-risk myelodysplastic syndrome in the U.S. Myelodysplastic syndromes (MDS) are a group of cancers where bone marrow doesn't produce enough healthy blood cells.FGEN stock is down by 28% this year but up by about 1% over the past 12 months.&nbsp;Read also: <a href="https://stocktwits.com/news-articles/markets/cryptocurrency/bitcoin-slips-under-116000-while-cardano-solana-lead-altcoin-selloff/chsO7iYRdQw">Bitcoin Slips Under $116,000 While Cardano, Solana Lead Altcoin Selloff</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Mission Bay headquarters and sign for FibroGen, a biotechnology company producing recombinant gelatins for medical devices and pharmaceuticals, San Francisco, California, 2016. (Photo by Smith Collection/Gado/Getty Images).

Fibrogen Gets Regulator’s Green Light To Sell China Unit To AstraZeneca

The company expects the transaction, which was announced in February, to close in the third quarter of 2025.

Equity

The company expects the transaction, which was announced in February, to close in the third quarter of 2025.


FibroGen (FGEN) Reports Q2 Loss, Lags Revenue Estimates

FibroGen (FGEN) delivered earnings and revenue surprises of -50.22% and -53.52%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

FibroGen (FGEN) Reports Q1 Loss, Tops Revenue Estimates

FibroGen Executives Depart Amid U.S. Operations Overhaul

The latest update is out from FibroGen ( ($FGEN) ). FibroGen, Inc. is streamlining its U.S. operations with a significant cost reduction strategy...

Pancreatic Cancer on the Rise: How Biotech Firms are Developing Groundbreaking Treatments

Pancreatic Cancer on the Rise: How Biotech Firms are Developing Groundbreaking Treatments Pancreatic Cancer on the Rise: How Biotech Firms are Developing Groundbreaking Treatments PR Newswire...

FibroGen Stock Is Surging After The Bell: What's Going On?

FibroGen shares are moving higher in Monday's after-hours session after the company announced the FDA cleared its Investigational New Drug (IND) FG-3165. The company also announced a new clinical...

Biotech Advances in 2024: Innovative Treatments Aim to Boost Pancreatic Cancer Survival Rates

Biotech Advances in 2024: Innovative Treatments Aim to Boost Pancreatic Cancer Survival Rates Biotech Advances in 2024: Innovative Treatments Aim to Boost Pancreatic Cancer Survival Rates PR Newswire...

FibroGen Shares Climb On Strong Q1 Sales

FibroGen reported quarterly losses of 33 cents per share which missed the analyst consensus estimate of $(0.31) and represents a 59.26% increase year-over-year. Quarterly sales clocked in at $55.902...

Notable Wednesday Option Activity: FGEN, PLCE, MDB

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in FibroGen Inc (FGEN), where a total volume of 13,026 contracts has been traded...

Commit To Buy FibroGen At $1, Earn 44.2% Annualized Using Options

Investors eyeing a purchase of FibroGen Inc (FGEN) stock, but tentative about paying the going market price of 1.30/share, might benefit from considering selling puts among the alternative...

FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993, and is headquartered in San Francisco, CA.

FibroGen Inc

$ASTS

$RKLB

$BBAI

$NBIS

Which earnings release are you most excited for the week of Nov. 10? 
 
Drop a comment for others.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	-$4.01	--	--	N/A
Q2 '25	-$2.30	-$1.88	18.38%	BEAT
Q1 '25	$0.03	$1.25	4066.67%	BEAT
Q4 '24	-$0.14	$0.18	228.57%	BEAT
Q3 '24	-$0.31	-$0.17	44.50%	BEAT

FGEN
FibroGen Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '25

Historical Earnings

Latest FGEN News

FGENFibroGen Inc